OpenAI Group PBC revealed today that it has acquired drug development software startup Orchestra Bio Inc. Orchestra builds artificial intelligence agents that help pharmaceutical teams keep development programs on track,. Its staff and technology will now sit inside OpenAI’s Rosalind life sciences unit. Much of OpenAI’s case for the deal comes down to how long […] The post OpenAI acquires Orchestra Bio to bring AI agents into drug development appeared first on SiliconANGLE.
Read the original at SiliconANGLE AI: OpenAI acquires Orchestra Bio to bring AI agents into drug development
How OpenSmartRoute helps
The router treats agents, tools and skills as targets in the same catalogue as models. An MCP tool or an A2A agent is one entry; the router picks it when it fits the request and learns from how it performs. The same guard and resource limits apply to a tool's arguments as to a prompt.
For a team that routes through the router, a release like this is one catalogue entry. The new model competes on the next request against what the team already runs, on quality, cost and speed. If it answers well it earns more traffic; if it fails it gets less, with no code change in the app.